Cargando…

Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population

INTRODUCTION: We evaluated whether concentrations of serum acylcarnitines and amino acids are associated with risk of type 2 diabetes and can improve predictive diabetes models in an Asian population. RESEARCH DESIGN AND METHODS: We used data from 3313 male and female participants from the Singapore...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunther, Samuel H, Khoo, Chin Meng, Tai, E-Shyong, Sim, Xueling, Kovalik, Jean-Paul, Ching, Jianhong, Lee, Jeannette J, van Dam, Rob M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534670/
https://www.ncbi.nlm.nih.gov/pubmed/33004401
http://dx.doi.org/10.1136/bmjdrc-2020-001315
_version_ 1783590348248842240
author Gunther, Samuel H
Khoo, Chin Meng
Tai, E-Shyong
Sim, Xueling
Kovalik, Jean-Paul
Ching, Jianhong
Lee, Jeannette J
van Dam, Rob M
author_facet Gunther, Samuel H
Khoo, Chin Meng
Tai, E-Shyong
Sim, Xueling
Kovalik, Jean-Paul
Ching, Jianhong
Lee, Jeannette J
van Dam, Rob M
author_sort Gunther, Samuel H
collection PubMed
description INTRODUCTION: We evaluated whether concentrations of serum acylcarnitines and amino acids are associated with risk of type 2 diabetes and can improve predictive diabetes models in an Asian population. RESEARCH DESIGN AND METHODS: We used data from 3313 male and female participants from the Singapore Prospective Study Program cohort who were diabetes-free at baseline. The average age at baseline was 48.0 years (SD: 11.9 years), and participants were of Chinese, Malay, and Indian ethnicity. Diabetes cases were identified through self-reported physician diagnosis, fasting glucose and glycated hemoglobin concentrations, and linkage to national disease registries. We measured fasting serum concentrations of 45 acylcarnitines and 14 amino acids. The association between metabolites and incident diabetes was modeled using Cox proportional hazards regression with adjustment for age, sex, ethnicity, height, and parental history of diabetes, and correction for multiple testing. Metabolites were added to the Atherosclerosis Risk in Communities (ARIC) predictive diabetes risk model to assess whether they could increase the area under the receiver operating characteristic curve (AUC). RESULTS: Participants were followed up for an average of 8.4 years (SD: 2.1 years), during which time 314 developed diabetes. Branched-chain amino acids (HR: 1.477 per SD; 95% CI 1.325 to 1.647) and the alanine to glycine ratio (HR: 1.572; 95% CI 1.426 to 1.733) were most strongly associated with diabetes risk. Additionally, the acylcarnitines C4 and C16-OH, and the amino acids alanine, combined glutamate/glutamine, ornithine, phenylalanine, proline, and tyrosine were significantly associated with higher diabetes risk, and the acylcarnitine C8-DC and amino acids glycine and serine with lower risk. Adding selected metabolites to the ARIC model resulted in a significant increase in AUC from 0.836 to 0.846. CONCLUSIONS: We identified acylcarnitines and amino acids associated with risk of type 2 diabetes in an Asian population. A subset of these modestly improved the prediction of diabetes when added to an established diabetes risk model.
format Online
Article
Text
id pubmed-7534670
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75346702020-10-07 Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population Gunther, Samuel H Khoo, Chin Meng Tai, E-Shyong Sim, Xueling Kovalik, Jean-Paul Ching, Jianhong Lee, Jeannette J van Dam, Rob M BMJ Open Diabetes Res Care Genetics/Genomes/Proteomics/Metabolomics INTRODUCTION: We evaluated whether concentrations of serum acylcarnitines and amino acids are associated with risk of type 2 diabetes and can improve predictive diabetes models in an Asian population. RESEARCH DESIGN AND METHODS: We used data from 3313 male and female participants from the Singapore Prospective Study Program cohort who were diabetes-free at baseline. The average age at baseline was 48.0 years (SD: 11.9 years), and participants were of Chinese, Malay, and Indian ethnicity. Diabetes cases were identified through self-reported physician diagnosis, fasting glucose and glycated hemoglobin concentrations, and linkage to national disease registries. We measured fasting serum concentrations of 45 acylcarnitines and 14 amino acids. The association between metabolites and incident diabetes was modeled using Cox proportional hazards regression with adjustment for age, sex, ethnicity, height, and parental history of diabetes, and correction for multiple testing. Metabolites were added to the Atherosclerosis Risk in Communities (ARIC) predictive diabetes risk model to assess whether they could increase the area under the receiver operating characteristic curve (AUC). RESULTS: Participants were followed up for an average of 8.4 years (SD: 2.1 years), during which time 314 developed diabetes. Branched-chain amino acids (HR: 1.477 per SD; 95% CI 1.325 to 1.647) and the alanine to glycine ratio (HR: 1.572; 95% CI 1.426 to 1.733) were most strongly associated with diabetes risk. Additionally, the acylcarnitines C4 and C16-OH, and the amino acids alanine, combined glutamate/glutamine, ornithine, phenylalanine, proline, and tyrosine were significantly associated with higher diabetes risk, and the acylcarnitine C8-DC and amino acids glycine and serine with lower risk. Adding selected metabolites to the ARIC model resulted in a significant increase in AUC from 0.836 to 0.846. CONCLUSIONS: We identified acylcarnitines and amino acids associated with risk of type 2 diabetes in an Asian population. A subset of these modestly improved the prediction of diabetes when added to an established diabetes risk model. BMJ Publishing Group 2020-10-01 /pmc/articles/PMC7534670/ /pubmed/33004401 http://dx.doi.org/10.1136/bmjdrc-2020-001315 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Genetics/Genomes/Proteomics/Metabolomics
Gunther, Samuel H
Khoo, Chin Meng
Tai, E-Shyong
Sim, Xueling
Kovalik, Jean-Paul
Ching, Jianhong
Lee, Jeannette J
van Dam, Rob M
Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population
title Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population
title_full Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population
title_fullStr Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population
title_full_unstemmed Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population
title_short Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population
title_sort serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic asian population
topic Genetics/Genomes/Proteomics/Metabolomics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534670/
https://www.ncbi.nlm.nih.gov/pubmed/33004401
http://dx.doi.org/10.1136/bmjdrc-2020-001315
work_keys_str_mv AT gunthersamuelh serumacylcarnitinesandaminoacidsandriskoftype2diabetesinamultiethnicasianpopulation
AT khoochinmeng serumacylcarnitinesandaminoacidsandriskoftype2diabetesinamultiethnicasianpopulation
AT taieshyong serumacylcarnitinesandaminoacidsandriskoftype2diabetesinamultiethnicasianpopulation
AT simxueling serumacylcarnitinesandaminoacidsandriskoftype2diabetesinamultiethnicasianpopulation
AT kovalikjeanpaul serumacylcarnitinesandaminoacidsandriskoftype2diabetesinamultiethnicasianpopulation
AT chingjianhong serumacylcarnitinesandaminoacidsandriskoftype2diabetesinamultiethnicasianpopulation
AT leejeannettej serumacylcarnitinesandaminoacidsandriskoftype2diabetesinamultiethnicasianpopulation
AT vandamrobm serumacylcarnitinesandaminoacidsandriskoftype2diabetesinamultiethnicasianpopulation